Michael Chi, the Chief Commercial Officer of Hims & Hers Health Inc (HIMS, Financial), sold 25,550 shares of the company on September 17, 2024, according to a recent SEC filing. Following this transaction, the insider now owns 193,980 shares of the company.
Hims & Hers Health Inc, a telehealth company that provides modern personalized health and wellness experiences to consumers, has seen a significant amount of insider trading activity over the past year. There have been 83 insider sells and only 1 insider buy during this period. Over the past year, Michael Chi has sold a total of 1,073,379 shares and has not purchased any shares.
On the day of the sale, shares of Hims & Hers Health Inc were trading at $16.5. This pricing values the company with a market cap of approximately $3.485 billion. The price-earnings ratio of the company stands at 201.25, which is significantly higher than the industry median of 17.57.
The stock is currently considered to be Fairly Valued with a price-to-GF Value ratio of 1.06, based on a GF Value of $15.52. The GF Value is calculated considering historical trading multiples, a GuruFocus adjustment factor based on past returns and growth, and future business performance estimates from Morningstar analysts.
This recent transaction by Michael Chi continues the trend of insider sells at Hims & Hers Health Inc, providing an interesting point of data for investors watching the company's stock performance and insider activities.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
